Document Type
Original Article
Abstract
Background: Current guidelines for acute ST-segment elevation myocardial infarction (STEMI) patients declared primary percutaneous coronary intervention (PPCI) as the mainstay reperfusion strategy. However, the no-reflow phenomenon(NRP) is a major drawback. The longer ischemia lasts, the more likely NRP is to occur causing more myocardial cells damage.
Aim of the Work: to correlate between the CHA2DS2VAScHS score and NPR in patient presented with STEMI and treated with PPCI.
Methods: Case-control study that included one hundred patients presented with STEMI and treated with PPCI. Patients were further divided into group(A) in which patients developed no-reflow (NR) after PPCI and group(B) in which patients achieved TIMI-III flow after PPCI. CHA2DS2VAScHS score was calculated for every patient.
Results: The study showed an increase in no-reflow in patients with higher CHA2DS2VAScHS score and no-reflow in STEMI patients treated with PPCI (p-value:0.000).
Conclusion: CHA2DS2VAScHS score is effective in the early prediction of NPR in patients with STEMI patients managed with PPCI.
Keywords
ST-segment elevation; Percutaneous Coronary Intervention; No-reflow.
Subject Area
Cardiology
How to Cite This Article
Allam, Sameh Refaat Hassan; Zahran, Alhussein Mostafa; and Elagami, Mohamed Ahmed Mohamed
(2023)
"CHA2DS2-VASc-HS Score as a Predictor of No-Reflow in Patients with ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Intervention,"
Al-Azhar International Medical Journal: Vol. 4:
Iss.
9, Article 27.
DOI: https://doi.org/10.58675/2682-339X.2042
